Subscribe
 

Celebrating ten years of productive partisanship.

x - close

Real World Evidence for Safe and Effective Cures: Medical Innovation for All Americans

KEYWORDS: FOOD AND DRUG ADMINISTRATION, BILL FRIST, LAMAR ALEXANDER, BART GORDON

WHEN: Thursday, June 23, 2016 5:00 a.m. to 7:00 a.m. ET

WHERE: Bipartisan Policy Center, 1225 Eye St. NW, Suite 1000, Washington, DC, 20005

Add to Calendar

The Bipartisan Policy Center hosted policy, scientific, industry, and patient leaders for a discussion on the latest advancements in medical innovation legislation. BPC also released new recommendations on the importance of using real world evidence to support finding safe and effective cures for Americans.

Today, emerging therapies offer promising cures for life-threatening diseases such as Alzheimer’s, cancer, Parkinson’s, etc. Pending legislation in Congress could streamline getting treatments and cures to patients. It will also bolster both the Food and Drug Administration and the National Institutes of Health to effectively carry out their roles in this charge. The vast increase in available data from electronic health records, claims systems, registries, and even patients themselves, also known as real world evidence, offers an opportunity to change the paradigm of evidence development for treatments in the U.S. Be our guest as we explore these topics.

Read the Report
Using Real-World Evidence to Accelerate Safe and Effective Cures

Join the discussion on Twitter: @BPC_Bipartisan #BPClive


A conversation with:

Sen. Lamar Alexander (R-TN)
Chairman, Senate Health, Education, Labor and Pensions Committee

William H. Frist, MD
Former Senate Majority Leader
Co-Chair, FDA: Advancing Medical Innovation, BPC

Bart Gordon
Former Representative from Tennessee
Co-Chair, FDA: Advancing Medical Innovation, BPC

Doug Oliver
Patient

Panel discussions with:

Marc Boutin, JD
CEO, National Health Council

Andrew von Eschenbach, MD
President, Samaritan Health Initiatives
Former FDA Commissioner

Adrian Hernandez, MD, MHS
Director, Duke Clinical Research Institute

David Madigan, PhD
Executive Vice President and Dean, Faculty of Arts and Sciences, Columbia University

Marcus D. Wilson, PharmD
President, HealthCore, Subsidiary of Anthem, Inc.

Janet Marchibroda
Director of Health Innovation, BPC

Closing remarks by:

Ted Giovanis
President, The Jayne Koskinas Ted Giovanis Foundation for Health and Policy